Skip to main content
. 1997 Aug 1;17(15):5820–5829. doi: 10.1523/JNEUROSCI.17-15-05820.1997

Table 1.

Density and cell fate of newborn cells in the subventricular zone, olfactory bulb, and striatum

Area aCSF FGF-2 EGF
Subventricular zone
 1 d after infusion
  Cannula side 62.2  ± 9.8 208.5  ± 62.21-160 595.5  ± 133.11-160
  Contralateral side 37.1  ± 8.1 32.6  ± 4.4 70.3  ± 9.91-160
 4 weeks after infusion
  Cannula side 30.6  ± 10.7 104.8  ± 27.71-160 153.6  ± 27.81-160
  Contralateral side 13.3  ± 3.9 13.5  ± 2.7 88.0  ± 11.81-160
Rostral migratory str.
 1 d after infusion 915.5  ± 50.0 714.4  ± 38.0* 368.8  ± 25.01-160
Olfactory bulb
 4 weeks after infusion
  Total 40.9  ± 2.0  (100) 46.9  ± 1.2*  (100) 16.3  ± 1.61-160  (100)
  Neurons 39.3  ± 1.6  (96) 45.2  ± 0.9*  (96) 11.8  ± 1.51-160  (72)
  Astrocytes 0.16  ± 0.11  (<0.1) 0.26  ± 0.10  (<0.1) 2.26  ± 0.541-160  (14)
Striatum
 4 weeks after infusion
  Total 2.8  ± 0.4  (100) 6.1  ± 0.81-160  (100) 12.3  ± 3.51-160  (100)
  Neurons 0  (0)  0  (0)  0  (0)
  Astrocytes 0.2  ± 0.1  (6) 1.4  ± 0.41-160  (22) 4.5  ± 1.41-160  (39)
  BrdU+/satellite cells 1.1  ± 0.1  (40) 3.2  ± 0.5*  (53) 5.2  ± 1.1*  (46)
  BrdU+/sat./astrocytes 0.05  ± 0.03  (1.8) 0.6  ± 0.2*  (10) 1.7  ± 0.7*  (14)

The brain areas were selected for unbiased quantification, as shown in Figure 1. Densities of newborn cells after aCSF, FGF-2, and EGF infusion are presented as the mean number of BrdU-positive cells (in thousands) per mm3 ± SEM.

*

p < 0.05;

F1-160: p < 0.01. To determine the cell type of BrdU-positive cells 4 weeks after infusion, we used NeuN as a marker for neurons and S100β for astrocytes. Percentages of cell types (numbers in parentheses) are based on the total density of BrdU-positive cells.